PleoPharma to Present New Cannabis Withdrawal Rese...
Category : Clinical Trial Update 16 June 2026PleoPharma has announced that it will present two scientific posters at the College on Problems of D...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Neurocrine Biosciences Shares New Long-Term Data f...
Category : Clinical Trial Update 16 June 2026Neurocrine Biosciences has announced new late-breaking data from the Phase 3 development program of...
Hillhurst Bio Doses First Patient in Phase 2a Tria...
Category : Clinical Trial Update 16 June 2026Hillhurst Biopharmaceuticals has announced an important milestone in its Parkinson’s disease p...
Celldex Reports Long-Term Phase 2 Data for Barzolv...
Category : Clinical Trial Update 16 June 2026Celldex Therapeutics has shared new long-term results from its Phase 2 study evaluating barzolvolima...
Mirum and Incyte Report Positive Phase 2 Results f...
Category : Clinical Trial Update 15 June 2026New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
Latest Newsletter Post
-
Celldex Reports Long-Term Phase 2 D..
16 June 2026
-
Hillhurst Bio Doses First Patient i..
16 June 2026
-
Neurocrine Biosciences Shares New L..
16 June 2026
-
PleoPharma to Present New Cannabis..
16 June 2026
-
Johnson & Johnson Expands TREMFYA A..
15 June 2026
